Paccar R&D increased by 2.7% to $109.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.5%, from $115.40M to $109.10M. Over 3 years (FY 2022 to FY 2025), R&D shows an upward trend with a 9.3% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $85.30M | $85.30M | $85.30M | $85.30M | $102.73M | $102.73M | $102.73M | $102.73M | $105.50M | $117.10M | $115.00M | $115.30M | $115.40M | $112.90M | $111.00M | $106.20M | $109.10M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +20.4% | +0.0% | +0.0% | +0.0% | +2.7% | +11.0% | -1.8% | +0.3% | +0.1% | -2.2% | -1.7% | -4.3% | +2.7% |
| YoY Change | — | — | — | — | +20.4% | +20.4% | +20.4% | +20.4% | +2.7% | +14.0% | +11.9% | +12.2% | +9.4% | -3.6% | -3.5% | -7.9% | -5.5% |
| Segment | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 |
|---|---|---|---|---|---|
| Truck Parts And Other | $108.90M | $117.10M | $115.00M | $115.30M | $115.40M |
| Total | $102.73M | $117.10M | $115.00M | $115.30M | $115.40M |